Table 2. Physiologically individualized therapy based on renin/aldosterone phenotyping (30).
Primary aldosteronism/inappropriate aldosterone secretion | Liddle’s syndrome and variants (mutations affecting the function of the renal Na+ channel) | Renal/renovascular | |
---|---|---|---|
Renin | Low | Low | High |
Aldosterone | High | Low | High |
Primary treatment | Aldosterone antagonist (spironolactone, eplerenone); amiloride if eplerenone is not available for men† (rarely adrenalectomy) | Amiloride | Angiotensin receptor blocker, renin inhibitor (rarely revascularization) |
†, gynecomastia and mastalgia are common in men taking high doses of spironolactone. (Reproduced by permission of Oxford University Press from: Akintunde A, Nondi J, Gogo K, et al. Physiological Phenotyping for Personalized Therapy of Uncontrolled Hypertension in Africa. Am J Hypertens 2017;30:923-30).